Advancing Regenerative Medicine with an Automated, Quality Controlled Cell Culturing System
News May 13, 2008
Tecan is collaborating with tissue engineering researchers at the University of Zurich to develop an automated system for propagation of quality controlled cells that will be suitable for use in regenerative medicine therapies, such as intervertebral disc implants. The project is funded by the CTI, the Swiss Confederation’s innovation promotion agency.
Tecan’s new solution will control all necessary cell culture steps, including the isolation, seeding, proliferation, harvesting and analysis of cell lines and primary cells. Quality control will be maintained through two integrated detection devices that will determine the degree of cell confluence and detect the expression of cell type-specific genetic markers.
“I’m convinced that regenerative medicine through tissue engineering will become a clinical reality, but to reach our goals we urgently need automated cell culture systems focused on repeatability, robustness and data traceability,” said Prof Norbert Boos, Head of Spinal Surgery at the Orthopaedic University Hospital Balgrist, University of Zurich.
“For example, cell-based nuclear replacement of the intervertebral disc seems a feasible and minimally invasive treatment for discogenic back pain, but the approach will not succeed without highly sensitized, automated tissue culture. We are certain that Tecan has the know-how and the infrastructure to achieve our goals and we have had an excellent partnership so far,”
The platform will be easily adjusted for culture of multiple cell types, providing standardized and affordable treatment procedures for regenerative medicine.
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
Innate Reaction of Hematopoietic Stem Cells to Severe InfectionsNews
Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.READ MORE
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBL Course: Transgenic Animals - Micromanipulation Techniques
Apr 10 - Apr 11, 2018